By Justin Taylor, Vice President of Communications, Longevity Global (Special Guest Contributor)
Innovation and Investment to Beat Aging and Age-Related Disease
Longevity Global is coming to RESI Boston on Wednesday, September 17, with a full day of programming dedicated to innovation and investment in the longevity space. This curated track will highlight cutting-edge science, startup founders, and investors who are accelerating solutions for aging and age-related diseases.
The day begins with coffee, networking, and opening remarks, followed by a keynote from Eric Morgen, Co-founder of BioAge, setting the stage for thought-provoking discussions on advancing longevity research. Morning sessions feature presentations from leaders such as Raghav Seghal (Yale), Christin Glorioso, MD, PhD (CEO, NeuroAge and Longevity Global), and Spring Behrouz (Vincere Bio), who will share perspectives on mitochondrial aging and fundraising in the field.
A Pharma Chat with Suguna Rachakonda (VP, Insilico) and Jon McClain (Executive Director, Lilly) will provide an industry lens on where big pharma sees opportunities in longevity.
The afternoon program kicks off with a keynote from Sharon Rosenzweig-Lipson (CSO, Life Biosciences), followed by Umbereen S. Nehal, MD, MPH, MBA (Founder, HER Heard, MIT) on the importance of women’s health interventions in extending lifespan and healthspan. Additional sessions include Ethan Berg (Founder, Winthrop Estate) on the case for investing in longevity, alongside an Investor Panel featuring Sally Wang (Managing Partner, XPanse Ventures), Ruta Laukien (VP, US Capital; Managing Partner, GrayBella Capital), and Fiona Miller (Managing Partner, quadraScope).
The Innovation Panel, moderated by Tom Zuber (Managing Partner, Zuber Lawler), will showcase voices across legal, biotech, and clinical perspectives, with speakers Frank Gerratana (Partner, Calyx Law), Shane Hegarty (CSO, AXONIS), and Jay Luthar, MD (Founder, Lutanen Health).
The program culminates with the Longevity Global Pitch Competition (Series A), where startups will showcase their technologies to a panel of seasoned investors. Winners will be announced by Daniel Dacey and The Engine, which will also award the winning company a full year of lab space—an invaluable resource for advancing early-stage science.
The day closes with the RESI Cocktail Hour, featuring wine and hors d’oeuvres, offering attendees the chance to network and celebrate innovation.
By bringing Longevity Global to RESI, this track provides an unparalleled platform for entrepreneurs and investors focused on combating aging and age-related disease. From scientific insights to investment strategies, the agenda is designed to drive meaningful dialogue and new connections in this rapidly advancing field.
Join us at RESI Boston to connect with the innovators and investors defining the future of longevity. Learn more
Next Phase Newsletter 
Leave a comment